187 related articles for article (PubMed ID: 35061117)
1. Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa.
Ogunbajo A; Tsai AC; Kanki PJ; Mayer KH
AIDS Behav; 2022 Jul; 26(7):2363-2375. PubMed ID: 35061117
[TBL] [Abstract][Full Text] [Related]
2. Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.
Schoenberg P; Edwards OW; Merrill L; Martinez CA; Stephenson R; Sullivan PS; Jones J
J Int AIDS Soc; 2023 Mar; 26(3):e26077. PubMed ID: 36951057
[TBL] [Abstract][Full Text] [Related]
3. Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study.
Liu Y; Chu Z; Wang H; Huang X; Chen Y; Wang H; Zou D; Jiang Y; Geng W; Hu Q; Zhou B; Shang H
BMC Public Health; 2023 Dec; 23(1):2494. PubMed ID: 38093204
[TBL] [Abstract][Full Text] [Related]
4. Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey.
Fu J; Dai Z; Wang H; Si M; Chen X; Wu Y; Xiao W; Huang Y; Yu F; Mi G; Su X
PLoS One; 2023; 18(10):e0293297. PubMed ID: 37856527
[TBL] [Abstract][Full Text] [Related]
5. High Interest in Long-acting Injectable Pre-exposure Prophylaxis (LAI-PrEP) for HIV Prevention Among Men Who Have Sex With Men (MSM): Result From A Nationwide Survey in Malaysia.
Paudel K; Gupta S; Gautam K; Wickersham JA; Khati A; Azwa I; Ha T; Shrestha R
J Community Health; 2023 Jun; 48(3):513-521. PubMed ID: 36732459
[TBL] [Abstract][Full Text] [Related]
6. Willingness to Use Long-Acting Injectable PrEP Among PrEP Naïve Black and Hispanic Sexual Gender Minority Persons.
Okafor CN; Eaton L; Watson R
AIDS Behav; 2024 Jun; 28(6):2166-2174. PubMed ID: 38526639
[TBL] [Abstract][Full Text] [Related]
7. Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S.
Irie WC; Calabrese SK; Patel RR; Mayer KH; Geng EH; Marcus JL
AIDS Behav; 2022 Jul; 26(7):2212-2223. PubMed ID: 34985607
[TBL] [Abstract][Full Text] [Related]
8. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.
Shrestha R; DiDomizio EE; Kim RS; Altice FL; Wickersham JA; Copenhaver MM
J Subst Abuse Treat; 2020 Oct; 117():108058. PubMed ID: 32811633
[TBL] [Abstract][Full Text] [Related]
9. The Use of HIV Pre- and Postexposure Prophylaxis Among a Web-Based Sample of HIV-Negative and Unknown Status Cisgender and Transgender Sexual Minority Men: Cross-sectional Study.
John SA; Sizemore KM; Jimenez RH; Jones SS; Petroll AE; Rendina HJ
JMIR Public Health Surveill; 2022 Dec; 8(12):e31237. PubMed ID: 36306518
[TBL] [Abstract][Full Text] [Related]
10. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.
John SA; Zapata JP; Dang M; Pleuhs B; O'Neil A; Hirshfield S; Walsh JL; Petroll AE; Quinn KG
Sci Rep; 2023 Mar; 13(1):5116. PubMed ID: 36991027
[TBL] [Abstract][Full Text] [Related]
11. Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis.
Levy ME; Patrick R; Gamble J; Rawls A; Opoku J; Magnus M; Kharfen M; Greenberg AE; Kuo I
PLoS One; 2017; 12(8):e0183521. PubMed ID: 28827821
[TBL] [Abstract][Full Text] [Related]
12. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
Cheng CY; Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Terris-Prestholt F
BMC Public Health; 2019 Jul; 19(1):996. PubMed ID: 31340785
[TBL] [Abstract][Full Text] [Related]
13. Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia.
Chan C; Vaccher S; Fraser D; Grulich AE; Holt M; Zablotska-Manos I; Prestage GP; Bavinton BR
AIDS Behav; 2022 Jan; 26(1):88-95. PubMed ID: 34142274
[TBL] [Abstract][Full Text] [Related]
14. Perceived Barriers to and Facilitators of Long-Acting Injectable HIV PrEP Use Among Black, Hispanic/Latino, and White Gay, Bisexual, and Other Men Who Have Sex With Men.
Tran NK; Martinez O; Scheim AI; Goldstein ND; Welles SL
AIDS Educ Prev; 2022 Oct; 34(5):365-378. PubMed ID: 36181495
[TBL] [Abstract][Full Text] [Related]
15. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.
Meyers K; Rodriguez K; Moeller RW; Gratch I; Markowitz M; Halkitis PN
PLoS One; 2014; 9(12):e114700. PubMed ID: 25502768
[TBL] [Abstract][Full Text] [Related]
16. Awareness, willingness to use, and history of HIV PrEP use among gay, bisexual, and other men who have sex with men in Nigeria.
Ogunbajo A; Iwuagwu S; Williams R; Biello K; Mimiaga MJ
PLoS One; 2019; 14(12):e0226384. PubMed ID: 31851722
[TBL] [Abstract][Full Text] [Related]
17. Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil.
Pedrana L; Magno L; Zucchi EM; da Silva LAV; Ferraz D; Grangeiro A; Castellanos M; Brasil SA; Dourado I
BMC Public Health; 2022 Sep; 22(1):1728. PubMed ID: 36096758
[TBL] [Abstract][Full Text] [Related]
18. Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.
Parsons JT; Rendina HJ; Whitfield TH; Grov C
AIDS Behav; 2016 Jul; 20(7):1390-9. PubMed ID: 27000145
[TBL] [Abstract][Full Text] [Related]
19. The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study.
Reyniers T; Fiorentino M; Babo SAY; Ouedraogo M; Kanta I; Agbegnigan LE; Rojas D; Anoma C; Dah TTE; Mensah E; Keita BD; Spire B; Vuylsteke B; Laurent C
AIDS Patient Care STDS; 2023 Oct; 37(10):480-488. PubMed ID: 37862074
[TBL] [Abstract][Full Text] [Related]
20. Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men.
Dean LT; Predmore Z; Skinner A; Napoleon S; Chan PA; Raifman J
AIDS Behav; 2023 Aug; 27(8):2606-2616. PubMed ID: 36670210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]